ArticleCureus2025
Selective Arterial Embolization for Persistent Urinoma Following Traumatic Renal Injury: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic and iatrogenic renal injuries, particularly high-grade trauma and complications following nephron-sparing surgeries, pose significant clinical challenges. Complications such as urinomas, pseudoaneurysms, and arteriovenous fistulas (AVFs) can lead to serious morbidity if not promptly addressed. Selective arterial embolization (SAE) has emerged as a minimally invasive alternative to surgery, offering effective hemorrhage control while preserving renal function. We report the case of a 51-year-old male patient who sustained a Grade V shattered left kidney following blunt trauma. The patient underwent emergency laparotomy with left nephrectomy. Postoperatively, a persistent urinoma developed from a retained kidney remnant. SAE was successfully performed to manage this complication, achieving complete resolution without further surgical intervention. SAE demonstrates high technical success and clinical efficacy in treating renal vascular complications after trauma or surgery. It offers the advantages of nephron preservation, reduced morbidity, and adaptability through various embolic agents. Despite risks such as post-embolization syndrome and potential non-target embolization, SAE remains the preferred approach in hemodynamically stable patients or those at high risk for reoperation. Early diagnosis and timely intervention are essential for optimal outcomes. SAE is a safe, effective, and nephron-sparing treatment modality for complex renal vascular injuries and complications. It should be considered a first-line therapeutic option in appropriate clinical settings, especially when surgical reintervention poses high risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.